Dupont Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Dupont Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$1.02M	–	781
2023 Q1	$1.02M	Hold	100,000	–	–	0.05%	201
2022 Q4	$1.01M	Hold	100,000	–	–	0.05%	351
2022 Q3	$986K	Hold	100,000	–	–	0.06%	398
2022 Q2	$974K	Hold	100,000	–	–	0.05%	490
2022 Q1	$976K	Hold	100,000	–	–	0.04%	524
2021 Q4	$976K	Hold	100,000	–	–	0.03%	541
2021 Q3	$978K	Buy	+100,000	New	+$976K	0.03%	579

Dupont Capital Management's ORIA Position: Q2 2023 in Review

Dupont Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Dupont Capital Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $1.02M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Dupont Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Dupont Capital Management sold 100,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.02M.
Dupont Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Dupont Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.02M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.